Kalaris Therapeutics, Inc. (KLRS) Live Share Price, Invest From India

Kalaris Therapeutics, Inc. Stock Performance

as on May 30, 2026 at 2:16 pm IST

Day's Low
Day's High
$5.11
Day's Price Range
$5.38
$5.27
3.04%
Downside
2.09%
Upside
52 Week's Low
52 Week's High
$2.14
52-Week Price Range
$11.88
$5.27
59.39%
Downside
125.43%
Upside

Kalaris Therapeutics, Inc. share price movements today

Previous Close: $5.18
Open: $5.22
Volume: 409.2K
Day's Low - High: $5.11 - $5.38
52 Week Low - High: $2.14 - $11.88

Kalaris Therapeutics, Inc. Historical Returns

1 Month Return: -5.99 %
3 Month Return: -50.48 %
1 Year Return: + 75 %
3 Year Return: 0 %
5 Year Return: 0 %

Kalaris Therapeutics, Inc. Stock Fundamentals & Key Indicators

Check Kalaris Therapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$124.7M

EPS (TTM)

-2.0514

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

-66.60%

Kalaris Therapeutics, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Kalaris Therapeutics, Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Kalaris Therapeutics, Inc.	NA	$124.7M	NA	NA	0.00%	NA
Alnylam Pharmaceuticals Inc	BUY	$39.5B	114.85%	74.09	12.55%	NA
Vertex Pharmaceuticals Inc	BUY	$111.0B	114.72%	25.98	35.51%	NA
Regeneron Pharmaceuticals Inc	BUY	$65.8B	23.7%	15.34	29.65%	0.5599999999999999%

Stock Returns calculator for Kalaris Therapeutics, Inc. Stock including INR - Dollar returns

The Kalaris Therapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Kalaris Therapeutics, Inc. investment value today

Current value as on today

₹1,98,142

Returns

₹98,142

(+98.14%)

Returns from Kalaris Therapeutics, Inc. Stock

₹78,041 (+78.04%)

Dollar Impact

₹20,101 (+20.1%)

Indian Investors' Interest in Kalaris Therapeutics, Inc. Stock

Search interest for Kalaris Therapeutics, Inc. Stock has increased by 71% in the last 30 days, reflecting an upward trend in search activity.

Time period: May 2, 2026 to June 1, 2026

Change:71% versus previous 30 day period

Kalaris Therapeutics, Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	0	0
Operating Income	-3	-2	-4	-37	-19	-10	-12	-12	-10	-11
EBITDA	-3	-3	-5	-37	-18	-8	-11	-11	-10	-11
Interest Expense	0	0	0	0	1	1	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	0	0
Income Before Tax	-3	-3	-5	-38	-18	-10	-11	-11	-9	-10
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-3	-3	-5	-38	-18	-10	-11	-11	-9	-10
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Kalaris Therapeutics, Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	1	0	-	-	-	-
Gross Profit	-	-	-	-	-	0
Operating Income	-3	-26	-14	-13	-55	-46
EBITDA	-2	-23	-15	-14	-58	-46
Interest Expense	-	-	0	0	2	1
Depreciation	-	-	-	-	-	0
Income Before Tax	-2	-23	-15	-14	-58	-43
Income Tax Expense	-	-	-	-	-	-
Net Income	-2	-23	-15	-14	-58	-43
Net Profit Margin	-214.10%	-14447.88%	0.00%	0.00%	0.00%	0.00%

Kalaris Therapeutics, Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-3	-5	-38	-22	-10	-11	-11	-9	-10
Operating Cash Flow	-4	-3	-4	-7	-7	-14	-11	-9	-13
Investing Cash Flow	-	-	-	-	-	-	-34	14	-50
Financing Cash Flow	6	4	0	7	107	2	-	50	0
Change in Cash	2	1	12	0	99	-12	-46	55	-63

Kalaris Therapeutics, Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-23	-69	-171	-15	-14	-58	-43
Operating Cash Flow	-20	-60	-106	-9	-14	-67	-42
Investing Cash Flow	-64	-169	185	-	-	95	-19
Financing Cash Flow	120	291	0	12	14	0	159
Change in Cash	36	61	79	3	0	28	-20

Global Institutional Holdings in Kalaris Therapeutics, Inc.

Funds	Holdings
Woodline Partners LP	0.43%
683 Capital Management LLC	0.2%
Siren, L.L.C.	1.9%
Ikarian Capital, LLC	1.57%
WHI TRUST Co LLC	0.42%

See all

Insights on Kalaris Therapeutics, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 1 Year
In the last 1 year, KLRS has outperformed top 5 stocks with highest market-cap in its industry
NO EFFECT
Against Peers
In the last 3 years, Kalaris Therapeutics, Inc. Common Stock has experienced a drawdown of -93.9%, however Alnylam Pharmaceuticals, Inc. Common Stock resisted the overall trend and outperformed by 77.5%
NEGATIVE IMPACT
Price Dip
In the last 3 months, KLRS stock has moved down by -49.6%

About Kalaris Therapeutics, Inc.

Kalaris Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of treatments for prevalent retinal diseases. It develops TH103, a clinical-stage anti-vascular endothelial growth factor (VEGF) drug for the treatment of neovascular age-related macular degeneration (nAMD), which is in Phase 1b/2, as well as for the treatment of other exudative and neovascular retinal diseases. Kalaris Therapeutics, Inc. was formerly known as Theia Therapeutics, Inc. and changed its name to Kalaris Therapeutics, Inc. in May 2024. The company was founded in 2019 and is headquartered in Berkeley Heights, New Jersey.

Organisation	Kalaris Therapeutics, Inc.
Headquarters	400 Connell Drive, Berkeley Heights, NJ, United States, 07922
Industry	Biotechnology
CEO	Mr. Andrew Oxtoby
E-voting on shares	Click here to vote

Key Management of Kalaris Therapeutics, Inc.

Name	Title
Dr. Napoleone Ferrara M.D.	Independent Director & Co-Founder
Mr. Brett R. Hagen	Chief Accounting Officer and Principal Accounting & Financial Officer
Dr. Matthew Feinsod M.D.	Chief Medical Officer
Ms. Kristine Curtiss	Senior Vice President of Clinical
Dr. Jill E. Porter Ph.D.	Senior Vice President of CMC
Mr. Andrew Oxtoby	President, CEO & Director
Dr. Srinivas Akkaraju M.D., Ph.D.	Director & Co-Founder
Dr. Michael Philip Dybbs Ph.D.	Co-Founder & Director

FAQs

What is Kalaris Therapeutics, Inc. share price today?

Kalaris Therapeutics, Inc. share price today is $5.27 as on May 30, 2026 at 8:46 am IST at the close of the market. Kalaris Therapeutics, Inc. share today touched a day high of $5.38 and a low of $5.11.

What is the 52 week high and 52 week low for Kalaris Therapeutics, Inc. share?

Kalaris Therapeutics, Inc. share touched a 52 week high of $11.88 on December 18, 2025 and a 52 week low of $2.14 on August 14, 2025. Kalaris Therapeutics, Inc. stock price today i.e. May 30, 2026 at 8:46 am IST is closed at $5.27,which is 55.64% down from its 52 week high and 146.26% up from its 52 week low.

What is Kalaris Therapeutics, Inc.'s market capitalisation today?

Kalaris Therapeutics, Inc. market capitalisation is $0.00T as on May 30, 2026 at 8:46 am IST.

How to invest in Kalaris Therapeutics, Inc. Stock (KLRS) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Kalaris Therapeutics, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Kalaris Therapeutics, Inc. Shares that will get you 0.2846 shares as per Kalaris Therapeutics, Inc. share price of $5.27 per share as on May 30, 2026 at 8:46 am IST.

What is the minimum amount required to buy Kalaris Therapeutics, Inc. Stock (KLRS) from India?

Indian investors can start investing in Kalaris Therapeutics, Inc. (KLRS) shares with as little as ₹94.99 or $1 (as of June 1, 2026 at 1:05 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹949.90 in Kalaris Therapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on June 1, 2026 at 1:05 am IST). Based on Kalaris Therapeutics, Inc. share’s latest price of $5.27 as on May 30, 2026 at 8:46 am IST, you will get 1.8975 shares of Kalaris Therapeutics, Inc.. Learn more about fractional shares .